San Francisco Sentry Investment Group’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-114
Closed -$12K 966
2019
Q3
$12K Hold
114
0.01% 537
2019
Q2
$11K Sell
114
-1,000
-90% -$95K 0.01% 549
2019
Q1
$105K Buy
1,114
+66
+6% +$5.77K 0.05% 301
2018
Q4
$67K Sell
1,048
-156
-13% -$11.5K 0.03% 339
2018
Q3
$107K Sell
1,204
-406
-25% -$35.9K 0.04% 307
2018
Q2
$128K Sell
1,610
-10,465
-87% -$869K 0.05% 271
2018
Q1
$1.08M Sell
12,075
-403
-3% -$38.7K 0.31% 62
2017
Q4
$1.3M Sell
12,478
-4,611
-27% -$520K 0.38% 54
2017
Q3
$2.49M Sell
17,089
-582
-3% -$79.3K 0.84% 21
2017
Q2
$2.29M Buy
17,671
+915
+5% +$112K 0.82% 24
2017
Q1
$2.08M Buy
16,756
+1,033
+7% +$124K 1.15% 19
2016
Q4
$1.82M Sell
15,723
-1,035
-6% -$115K 1.05% 22
2016
Q3
$1.75M Sell
16,758
-1,200
-7% -$130K 1.04% 24
2016
Q2
$1.77M Sell
17,958
-640
-3% -$66.2K 1.09% 25
2016
Q1
$1.86M Sell
18,598
-10
-0.1% -$1.03K 1.12% 22
2015
Q4
$2.23M Buy
18,608
+50
+0.3% +$5.79K 1.4% 14
2015
Q3
$2.01M Sell
18,558
-70
-0.4% -$8.69K 1.41% 14
2015
Q2
$2.16M Sell
18,628
-627
-3% -$71.7K 1.29% 14
2015
Q1
$2.22M Sell
19,255
-7,677
-29% -$917K 1.32% 13
2014
Q4
$3.01M Sell
26,932
-322
-1% -$34K 1.74% 8
2014
Q3
$2.58M Sell
27,254
-5,355
-16% -$483K 1.29% 9
2014
Q2
$2.8M Sell
32,609
-835
-2% -$63.5K 1.34% 8
2014
Q1
$2.33M Sell
33,444
-2,900
-8% -$230K 0.75% 28
2013
Q4
$3.07M Sell
36,344
-1,250
-3% -$98.9K 1.06% 18
2013
Q3
$2.9M Sell
37,594
-882
-2% -$61.8K 1.09% 15
2013
Q2
$2.25M Buy
+38,476
New +$2.32M 0.81% 27

Other funds holding CELG

San Francisco Sentry Investment Group's CELG Position: Q4 2019 in Review

San Francisco Sentry Investment Group sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 114 shares — an estimated $12K sold.

San Francisco Sentry Investment Group first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $3.07M in Q4 2013. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • San Francisco Sentry Investment Group reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • San Francisco Sentry Investment Group sold 114 Celgene Corp shares in Q4 2019, an estimated $12K.
  • San Francisco Sentry Investment Group first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • San Francisco Sentry Investment Group's Celgene Corp position peaked at $3.07M in Q4 2013.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on San Francisco Sentry Investment Group's 13F filing for Q4 2019, filed 30 Jan 2020.